The company, which began a decade ago, has grown from humble beginnings to now include a factory in Piscataway and a second site in Philadelphia.

The U.S. Food and Drug Administration is raising alarms about Librela, warning veterinarians of potential adverse effects, including death, in some dogs receiving the treatment.